UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

HIV-DNA, CD32a CD4+ T-cells and immune activation on successfull dolutegravir-based regimen

Journal of Virus Eradication, 2017-12, Vol.3, p.30

2017

Volltextzugriff (PDF)

Spread of HIV-DNA in CD4+ T-cells subsets depends on ART initiation timing

Journal of Virus Eradication, 2017-12, Vol.3, p.29-30

2017

Volltextzugriff (PDF)

First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2)

Clinical infectious diseases, 2018-09, Vol.67 (8), p.1161-1167

2018

Volltextzugriff (PDF)

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial

Clinical infectious diseases, 2009-11, Vol.49 (9), p.1441-1449

2009

Volltextzugriff (PDF)

Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants

Bone marrow transplantation (Basingstoke), 1992-04, Vol.9 (4), p.285-291

1992

Volltextzugriff (PDF)

Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial

Journal of acquired immune deficiency syndromes (1999), 2012-04, Vol.59 (5), p.489

2012

Volltextzugriff (PDF)

Difficulties in collecting peripheral blood stem cells in chronic myeloid leukemia related to persistence of the leukemic cell clone

Stem cells (Dayton, Ohio), 1993-10, Vol.11 Suppl 3, p.43

1993

Volltextzugriff (PDF)

Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from FranceResearch in context

The Lancet regional health. Europe, 2024-05, Vol.40, p.100885

2024

Volltextzugriff (PDF)

Trends in post-infection CD4 cell counts and plasma HIV-1 RNA levels in HIV-1-infected patients in France between 1997 and 2005

Journal of acquired immune deficiency syndromes (1999), 2009-11, Vol.52 (3), p.422

2009

Volltextzugriff (PDF)

Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV

AIDS (London), 2012-03, Vol.26 (6), p.711-720

2012

Volltextzugriff (PDF)

Survival after neuroAIDS: association with antiretroviral CNS Penetration-Effectiveness score

Neurology, 2011-02, Vol.76 (7), p.644

2011

Volltextzugriff (PDF)

Comparative survival, quality of life and cost-effectiveness of intensive therapy with autologous blood cell transplantation or conventional chemotherapy in multiple myeloma

Bone marrow transplantation (Basingstoke), 1995-07, Vol.16 (1), p.19-25

1995

Volltextzugriff (PDF)

Interleukin-2 before Antiretroviral Therapy in Patients with HIV Infection: A Randomized Trial (ANRS 119)

The Journal of infectious diseases, 2009-07, Vol.200 (2), p.206-215

2009

Volltextzugriff (PDF)

Inadequate vaccination coverage in a French cohort of HIV positive patients

Médecine et maladies infectieuses, 2010-12, Vol.40 (12), p.683-690

2010

Volltextzugriff (PDF)

Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4

Archives of internal medicine (1960), 2010-07, Vol.170 (14), p.1228

2010

Volltextzugriff (PDF)

HIV-associated tuberculosis and immigration in a high-income country: incidence trends and risk factors in recent years

AIDS (London), 2010-03, Vol.24 (5), p.763-771

2010

Volltextzugriff (PDF)

Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir

Journal of antimicrobial chemotherapy, 2011-08, Vol.66 (8), p.1869-1877

2011

Volltextzugriff (PDF)

IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy—results from the ANRS CO4 cohort

Journal of antimicrobial chemotherapy, 2010-10, Vol.65 (10), p.2215-2223

2010

Volltextzugriff (PDF)

Insuffisance de couverture vaccinale d’une cohorte française de patients séropositifs VIH

Médecine et maladies infectieuses, 2010-12, Vol.40 (12), p.683-690

2010

Volltextzugriff (PDF)

Interleukine-2 Therapy Does Not Increase the Risk of Hodgkin or Non-Hodgkin Lymphoma in HIV-Infected Patients: Results From FHDH ANRS CO4

Journal of acquired immune deficiency syndromes (1999), 2009-02, Vol.50 (2), p.206, Article 206

2009

Volltextzugriff (PDF)

Unequal results of collection of peripheral blood stem cells in view of autografting in high risk multiple myeloma

Bone marrow transplantation (Basingstoke), 1990, Vol.5, p.56-57

1990

Volltextzugriff (PDF)

Coma hyperosmolaire et inhibiteurs de protéase

Journal de pharmacie clinique, 1998-09, Vol.17 (3), p.178-179

1998

Volltextzugriff (PDF)

776 Aids-related malignancies: Analysis of 168 cases registered in alsace

European journal of cancer (1990), 1995-11, Vol.31, p.S162-S163

1995

Volltextzugriff (PDF)

A-02 Statut vaccinal de la population séropositive VIH en Alsace en 2007 : étude prospective observationnelle

Médecine et maladies infectieuses, 2008-06, Vol.38, p.S133-S133

2008

Volltextzugriff (PDF)

Acrosyndromes induced by bleomycin in HIV 1 related Kaposi's disease. 5 cases

La Presse médicale (1983), 1997-11, Vol.26 (33), p.1564

1997

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(32)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Humans
(20)
Life Sciences & Biomedicine
(20)
Male
(18)
Female
(17)
Adult
(16)
Middle Aged
(15)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Infectious Diseases
(13)
Immunology
(12)
Hiv
(9)
Human Viral Diseases
(9)
Viral Diseases
(9)
Hiv Infections - Drug Therapy
(8)
Human Immunodeficiency Virus
(8)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(8)
Microbiology
(7)
Aids/hiv
(6)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

HIV-DNA, CD32a CD4+ T-cells and immune activation on successfull dolutegravir-based regimen

Spread of HIV-DNA in CD4+ T-cells subsets depends on ART initiation timing

First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2)

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial

Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants

Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial

Difficulties in collecting peripheral blood stem cells in chronic myeloid leukemia related to persistence of the leukemic cell clone

Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from FranceResearch in context

Trends in post-infection CD4 cell counts and plasma HIV-1 RNA levels in HIV-1-infected patients in France between 1997 and 2005

Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV

Survival after neuroAIDS: association with antiretroviral CNS Penetration-Effectiveness score

Comparative survival, quality of life and cost-effectiveness of intensive therapy with autologous blood cell transplantation or conventional chemotherapy in multiple myeloma

Interleukin-2 before Antiretroviral Therapy in Patients with HIV Infection: A Randomized Trial (ANRS 119)

Inadequate vaccination coverage in a French cohort of HIV positive patients

Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4

HIV-associated tuberculosis and immigration in a high-income country: incidence trends and risk factors in recent years

Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir

IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy—results from the ANRS CO4 cohort

Insuffisance de couverture vaccinale d’une cohorte française de patients séropositifs VIH

Interleukine-2 Therapy Does Not Increase the Risk of Hodgkin or Non-Hodgkin Lymphoma in HIV-Infected Patients: Results From FHDH ANRS CO4

Unequal results of collection of peripheral blood stem cells in view of autografting in high risk multiple myeloma

Coma hyperosmolaire et inhibiteurs de protéase

776 Aids-related malignancies: Analysis of 168 cases registered in alsace

A-02 Statut vaccinal de la population séropositive VIH en Alsace en 2007 : étude prospective observationnelle

Acrosyndromes induced by bleomycin in HIV 1 related Kaposi's disease. 5 cases

Suchergebnisse filtern